Peripheral Arterial Disease From a Community Pharmacy Perspective

被引：0
|
作者：
Hayes, Harskin H. J., Jr. [1 ,2 ]
Colvin, Natasha N. [1 ]
Dalton, Erin E. [3 ]
Sally, Chelcy [4 ]
机构：
[1] South Univ, Sch Pharm, Pharm Practice, Columbia, SC USA
[2] Sona Pharm, Specialty Pharm, Asheville, NC 28803 USA
[3] South Univ, Sch Pharm, Pharm Practice, Savannah, GA USA
[4] South Univ, Sch Pharm, Columbia, SC USA
来源：
US PHARMACIST | 2019年 / 44卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Peripheral arterial disease (PAD) affects 202 million people worldwide, including 8.5 million people in the United States. It is caused by atherosclerosis that leads to limited blood flow in the legs and other parts of the body. There are several treatment options available, but awareness of the disease and how it can be prevented needs to be increased. Community pharmacists can have a significant impact on patients with PAD by encouraging a healthy lifestyle and smoking cessation for prevention and by assisting in medication adherence to improve outcomes.
引用
收藏
页码：25 / 31
页数：7
相关论文
共 50 条
  • [1] Pharmacist-initiated peripheral arterial disease screening program in a community pharmacy setting
    Winfrey, Cameron
    Wortman, Sara
    Frede, Stacey
    Kunze, Natalie
    Conrad, Wayne F.
    Heaton, Pamela C.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2011, 51 (03) : 373 - U91
  • [2] The DAPT Trial and Peripheral Arterial Disease From a Vascular Medicine Perspective
    Eckstein, Hans-Henning
    Stadlbauer, Thomas
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (09) : 955 - 957
  • [3] Betablockers and peripheral arterial disease: a new perspective
    Martinez Coba, Manuel
    GALICIA CLINICA, 2009, 70 (03): : 7 - 8
  • [4] HOSPITALIZATION AFTER DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE IN THE COMMUNITY
    Arruda-Olson, Adelaide Maria
    Abram, Sara
    Lewis, Bradley
    Isseh, Iyad
    Haddad, Raad
    Scott, Christopher
    Kullo, Iftikhar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A2065 - A2065
  • [5] Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease
    Rehring, Thomas F.
    Stolcpart, Ryan S.
    Sandhoff, Brian G.
    Merenich, John A.
    Hollis, H. Whitton, Jr.
    JOURNAL OF VASCULAR SURGERY, 2006, 43 (06) : 1205 - 1209
  • [6] Screening for peripheral arterial disease in a rural community health setting
    Coe, Evelyn R.
    JOURNAL OF VASCULAR NURSING, 2014, 32 (04) : 137 - +
  • [7] Peripheral arterial disease - Management of peripheral arterial disease in the elderly
    Aronow, Wilbert S.
    GERIATRICS-US, 2007, 62 (01): : 19 - 25
  • [8] Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease - Discussion
    Rehring, TF
    Baker, JD
    Nehler, M
    Merrell, S
    JOURNAL OF VASCULAR SURGERY, 2006, 43 (06) : 1209 - 1210
  • [9] The peripheral arterial disease coalition and peripheral arterial disease awareness campaign
    Lovell, Marge
    JOURNAL OF VASCULAR NURSING, 2007, 25 (04) : 94 - +
  • [10] Patients' Perspective about Risks and Benefits of Treatment for Peripheral Arterial Disease
    Zafar, Abdul M.
    Harris, Tyler J.
    Murphy, Timothy P.
    Machan, Jason T.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 22 (12) : 1657 - 1661
12345